Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Major

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Virology|September 1, 1995
DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidM E Major, L Vitvitski, M A Mink, et al.
Journal of Virology|March 12, 1999
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virusM E Major, K Mihalik, J Fernandez, et al.
Journal of Virology|September 1, 1997
Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection modeI Nakano, G Maertens, M E Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse modelT Arichi, T Saito, M E Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2001
RetractionT Arichi, T Saito, M E Major, et al.
Vaccine|May 12, 2009
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutationI Zubkova, Y H Choi, E Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2004
Neutralizing antibody response during acute and chronic hepatitis C virus infectionC Logvinoff, M E Major, D Oldach, et al.
Disability and Rehabilitation|August 5, 2024
Experiences with hospital-to-home transitions: perspectives from patients, family members and healthcare professionals. A systematic review and meta-synthesis of qualitative studiesJ W M van Grootel, R J Collet, J M van Dongen, et al.
Journal of Clinical Nursing|March 27, 2025
Continuity and Coordination of Care During Hospital-To-Home Transitions: Healthcare Professionals' PerspectivesJ W M van Grootel, R J Collet, J M van Dongen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable regionM Shirai, T Arichi, M Chen, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Virology|September 1, 1995
DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidM E Major, L Vitvitski, M A Mink, et al.
Journal of Virology|March 12, 1999
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virusM E Major, K Mihalik, J Fernandez, et al.
Journal of Virology|September 1, 1997
Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection modeI Nakano, G Maertens, M E Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse modelT Arichi, T Saito, M E Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2001
RetractionT Arichi, T Saito, M E Major, et al.
Vaccine|May 12, 2009
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutationI Zubkova, Y H Choi, E Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2004
Neutralizing antibody response during acute and chronic hepatitis C virus infectionC Logvinoff, M E Major, D Oldach, et al.
Disability and Rehabilitation|August 5, 2024
Experiences with hospital-to-home transitions: perspectives from patients, family members and healthcare professionals. A systematic review and meta-synthesis of qualitative studiesJ W M van Grootel, R J Collet, J M van Dongen, et al.
Journal of Clinical Nursing|March 27, 2025
Continuity and Coordination of Care During Hospital-To-Home Transitions: Healthcare Professionals' PerspectivesJ W M van Grootel, R J Collet, J M van Dongen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable regionM Shirai, T Arichi, M Chen, et al.
Pageof 3